February 25, 2020
LifeOmic, the maker of apps and other software for providers, has snagged former HHS CTO Ed Simcox as its new chief strategy officer. This role will task Simcox with development of the company’s health and security product strategies, as well as with the coordination of B2B partnerships and other relationships.
“Ed provides LifeOmic with invaluable experience helping change the way people...
December 10, 2019
Remote vital sign monitoring company Current Health (formerly snap40) has completed an $11.5 million Series A round of financing headed by MMC Ventures, the Edinburgh, London and San Francisco-based company announced this morning.
Legal & General played a major role in the raise as the heaviest backer and Current’s first corporate investor, with additional funds coming from Par Equity and...
October 1, 2019
Edinburgh, Scotland-based patient monitoring wearable and platform company Current Health (formerly snap40) has cut deals with fellow connected monitor maker VivaLNK and spirometry device company MIR (Medical International Research) to add axillary temperature and spirometry measurement capabilities to its offering.
Enabled by a 510(k) clearance posted by the FDA back in July, these types of...
July 19, 2019
This quarter was another busy one for the FDA as it continued to reevaluate its approach to digital health amidst a changing of the guard from Dr. Scott Gottlieb to its new commissioner, Dr. Norman "Ned" Sharpless.
Among its most notable digital health actions of the past few months was the agency’s decision to put out a call for new companies to try out the current framework of its Digital...
July 18, 2019
Lumeon, a digital health startup that employs automation to help with operational functions, has brought on a new CFO and chairman of the board. Mark Clermont, former president of recently acquired Provant Health, will take on the former position, while Dr. Carl Schramm, a professor at Syracuse University and former president of the Ewing Marion Kauffman Foundation, will hold the latter.
April 24, 2019
In February, Edinburgh, Scotland-based Current Health (formerly snap40) received FDA clearance for clinical use of its artificial intelligence-enabled device and platform for remote patient monitoring in the hospital.
Taking things one step further, the company announced this morning that it has also received the regulator’s blessing for use in post-acute care — what Current Health is calling “...
February 6, 2019
Edinburgh-headquartered Current Health, formerly known as snap40, has received FDA Class II clearance for its remote patient monitoring solution, the Scottish start-up announced today.
Current's AI-enabled wearable monitors vital signs with “ICU-level accuracy”, according to the start-up, and proprietary algorithms analyse data to offer insights into a patient’s health, alerting staff in case...